Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$192.64 - $288.27 $337,120 - $504,472
-1,750 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$217.95 - $332.25 $760,645 - $1.16 Million
-3,490 Reduced 66.6%
1,750 $495,000
Q1 2021

May 17, 2021

SELL
$192.6 - $274.3 $295,833 - $421,324
-1,536 Reduced 22.67%
5,240 $1.11 Million
Q4 2020

Feb 16, 2021

SELL
$140.49 - $206.89 $267,633 - $394,125
-1,905 Reduced 21.94%
6,776 $1.33 Million
Q3 2020

Nov 16, 2020

BUY
$141.27 - $182.68 $435,676 - $563,385
3,084 Added 55.1%
8,681 $1.43 Million
Q2 2020

Aug 14, 2020

BUY
$57.19 - $138.77 $320,092 - $776,695
5,597 New
5,597 $777,000
Q2 2018

Aug 14, 2018

SELL
$91.9 - $176.53 $3.42 Million - $6.56 Million
-37,160 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$63.32 - $93.45 $2.35 Million - $3.47 Million
37,160 New
37,160 $3.47 Million

Others Institutions Holding MED

About MEDIFAST INC


  • Ticker MED
  • Exchange NYSE
  • Sector Consumer Cyclical
  • Industry Personal Services
  • Shares Outstandng 11,017,900
  • Market Cap $203M
  • Description
  • Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...
More about MED
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.